drugset
drugset / Trial / NCT02899741

Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study

NCT02899741 ↗

Phase 2 Unknown 30 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether omega-3 is effective in the treatment of medically intractable epilepsy as adjunctive therapy.

Timeline

Start
2016-08
Primary completion
2018-11
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 fatty acids Unknown 1000 mg —

Indications

epilepsy